secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0001213900-24-095002
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix director Levangie resigns; shareholders authorize share allotment up to ~35% of enlarged capital
--------------------------------------------------------------------------------

- Dan Levangie resigned as Non-Executive Director effective Oct 31, 2024, citing no disagreement.
- Shareholders passed all three resolutions with >98.7% votes in favor at Oct 31 general meeting.
- Board authorized share allotment up to ~35% of enlarged share capital; specific nominal amounts for bonds/placements.
- Julian Baines MBE appointed as director effective from close of GM with 99.85% votes in favor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000121390024095002/0001213900-24-095002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000121390024095002/ea0220145-8k_renalytix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-095002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer